(1)
MohanaSundaram, A.; Kesavan, G.; Nagaraj, K.; Ramesh, P. Donanemab for Alzheimer’s Disease: A Translational Milestone or Just Another Chapter in the Anti-Amyloid Antibody Story?. Am J Transl Med 2025, 9, 104-109.